Stockscreener 앱 받기
0.625
1.17%
0.0195
전일 마감가:
$0.6055
열려 있는:
$0.6
하루 거래량:
12,043
Relative Volume:
0.05
시가총액:
$14.46M
수익:
$62.71M
순이익/손실:
$-10.48M
주가수익비율:
-0.9921
EPS:
-0.63
순현금흐름:
$-13.77M
1주 성능:
+4.01%
1개월 성능:
-5.90%
6개월 성능:
-80.98%
1년 성능:
-87.50%
1일 변동 폭
$0.60
$0.6129
1주일 범위
$0.57
$0.67
52주 변동 폭
$0.56
$7.48
프로페이즈 Stock (PRPH) Company Profile
명칭
Prophase Labs Inc
전화
(215) 345-0919
주소
711 STEWART AVE, SUITE 200, NEW YORK, PA
PRPH을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
PRPH
Prophase Labs Inc
|
0.6125 | 14.46M | 62.71M | -10.48M | -13.77M | -0.63 |
|
TMO
Thermo Fisher Scientific Inc
|
560.90 | 213.05B | 42.37B | 6.14B | 7.78B | 15.95 |
|
DHR
Danaher Corp
|
240.62 | 171.63B | 23.74B | 3.89B | 4.98B | 5.24 |
|
A
Agilent Technologies Inc
|
145.94 | 40.96B | 6.51B | 1.29B | 1.37B | 4.42 |
|
IQV
Iqvia Holdings Inc
|
197.93 | 35.93B | 15.32B | 1.41B | 1.96B | 7.62 |
|
IDXX
Idexx Laboratories Inc
|
429.39 | 34.28B | 3.84B | 866.24M | 792.60M | 10.37 |
프로페이즈 Stock (PRPH) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2021-12-20 | 개시 | H.C. Wainwright | Buy |
| 2021-10-13 | 다운그레이드 | Dawson James | Buy → Neutral |
| 2021-01-20 | 개시 | Dawson James | Buy |
프로페이즈 주식(PRPH)의 최신 뉴스
PRPH (ProPhase Labs) Debt-to-EBITDA : -1.36 (As of Sep. 2024) - GuruFocus.com
ProPhase Labs stock hits 52-week low at $0.61 amid sharp decline - Investing.com Canada
ProPhase Labs Receives Notice from NASDAQ Regarding Minimum Bid Price Requirement On December 26, 2024, ProPhase Labs, Inc. (NASDAQ: PRPH) received a letter from the Listing Qualifications Staff of The Nasdaq Stock Market LLC, indicating that t - Defense World
ProPhase Labs faces potential Nasdaq delisting over share price By Investing.com - Investing.com Nigeria
ProPhase Labs faces potential Nasdaq delisting over share price - Investing.com
HighTower Advisors LLC Boosts Stock Position in ProPhase Labs, Inc. (NASDAQ:PRPH) - Defense World
ProPhase Labs stock hits 52-week low at $0.64 amid sharp decline - Investing.com Australia
ProPhase Labs stock hits 52-week low at $0.64 amid sharp decline By Investing.com - Investing.com South Africa
ProPhase Labs stock hits 52-week low at $0.66 amid sharp decline By Investing.com - Investing.com South Africa
ProPhase Labs stock hits 52-week low at $0.66 amid sharp decline - Investing.com
ProPhase Labs secures private equity backing, nears lozenge deal, and plans cost-cutting measures - MSN
ProPhase Labs Secures Global Private Equity Backing, Nears Major Lozenge Deal, Adds Seasoned Industry Expert, and Plans Significant Cost-Cutting Measures - The Manila Times
ProPhase Labs Secures Global Private Equity Backing, Nears - GlobeNewswire
ProPhase Labs Secures Game-Changing Financing Deal, Eyes Major Asian Market Expansion - StockTitan
PRPH (ProPhase Labs) 5-Day RSI : 18.93 (As of Dec. 05, 2024) - GuruFocus.com
ProPhase Labs Launches Genetic Testing Subsidiary with Advanced Technology - Precedence Research
PRPH (ProPhase Labs) Growth Rank : 9 (As of Nov. 26, 2024) - GuruFocus.com
ProPhase Labs, Inc. (NASDAQ:PRPH) Q3 2024 Earnings Call Transcript - MSN
ProPhase Labs plummets 21%, prices $3M equity offering - MSN
ProPhase Labs 4.17M share Spot Secondary priced at $.72 - MSN
ProPhase Labs, Inc. (PRPH) Reports Q3 Loss, Tops Revenue Estimates - MSN
ProPhase Labs Inc (PRPH) Q3 2024 Earnings Call Highlights: Strat - GuruFocus.com
ProPhase Labs Inc (PRPH) Q3 2024 Earnings Call Highlights: Strategic Launches and Financial ... - Yahoo Finance
ProPhase Labs Inc (PRPH) Q3 2024 Earnings Call Highlights: Strategic Launches and Financial ... By GuruFocus - Investing.com Canada
Diamond Equity Research Releases Update Note on ProPhase Labs Inc. (NASDAQ: PRPH) - EIN News
Earnings call: Prophase Labs' Q3 2024 reveals strategic growth initiatives By Investing.com - Investing.com Australia
Arcutis Biotherapeutics (NASDAQ:ARQT) versus ProPhase Labs (NASDAQ:PRPH) Critical Survey - Defense World
ProPhase Labs: Strategic Moves for Future Growth - TipRanks
ProPhase Labs Announces Financial Results for the Three Months Ended September 30, 2024 - The Manila Times
ProPhase Labs Announces Closing of Public Offering of Common Stock - GlobeNewswire
Wendys Company (WEN-Q) QuotePress Release - The Globe and Mail
Palantir Technologies Inc Cl A (PLTR-N) QuotePress Release - The Globe and Mail
ProPhase Labs Inc. to Present Third Quarter 2024 Financial Results on November 13, 2024 - GlobeNewswire
ProPhase Labs to Host Q3 2024 Earnings Call on November 13 | PRPH Stock | PRPH Stock News - StockTitan
ProPhase Labs announces proposed public offering of common stock - MSN
Investors Give ProPhase Labs, Inc. (NASDAQ:PRPH) Shares A 65% Hiding - Simply Wall St
It's Down 65% But ProPhase Labs, Inc. (NASDAQ:PRPH) Could Be Riskier Than It Looks - Simply Wall St
S&P 500 Tops 6,000; Sezzle Shares Spike Higher - Benzinga
Dow Tops 44,000; US Consumer Sentiment Increases In NovemberNature's Miracle Holding (NASDAQ:NMHI) - Benzinga
U.S. Stock market: FOXO Technologies(+134.66%) Northann Corp.(+67.38%) and ProPhase Labs(-47.43%) were the most volatile stocks during midday trading - Business Upturn
U.S. Stock market: Tivic Health up 138.62%, Northann surges 120.19%, ProPhase Labs down 50.70% among the most volatile stocks during early trading - Business Upturn
PRPHProPhase Labs, Inc. Latest Stock News & Market Updates - StockTitan
ProPhase Labs Prices of Public Offering of Common Stock - citybiz
ProPhase Labs Raises $3M in Public Offering at $0.72 Per Share, Stock Dilution Ahead | PRPH Stock News - StockTitan
ProPhase Labs Announces Pricing of Public Offering of Common Stock - GlobeNewswire
ProPhase Labs plans public stock offering - Investing.com India
프로페이즈 (PRPH) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.97%
자본화:
|
볼륨(24시간):